Eurofins CDMO

Planegg, DE · San Diego, CA
Biologics Cell Therapy
Program data pending ClinicalTrials.gov matching · Last scored 2026-03-15
65.5
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (4)

Quick Facts: Eurofins CDMO

Signal Score
65.5/100 (as of 2026-03-15)
Quality Compliance
Assessment pending
Headquarters
Planegg, DE · San Diego, CA
Modalities
Biologics, Cell Therapy
Active CGT Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CGT manufacturing intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesBiologics, Cell Therapy
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 68.0
Parent company: Eurofins Scientific
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Subsidiary of Eurofins Scientific
SEC FilingsParent: Eurofins Scientific
Parent company: Eurofins Scientific
Financial assessment: 68.0/100
Capacity 63.0
2 CGT manufacturing sites
Sites: Planegg, DE, San Diego, CA
Source: SEC EDGAR, press monitoring, company profiles
2 CGT manufacturing sites
Recent Press4 articles
2 CGT manufacturing sites

Recent News 4 articles

general 2026-03-10
Polyrizon makes GMP batch for planned U.S. nasal allergy, virus trial - Stock Titan
Polyrizon makes GMP batch for planned U.S. nasal allergy, virus trial  Stock Titan
Source →
general 2026-03-10
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - The Manila Times
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study  The Manila Times
Source →
general 2026-03-10
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ... - Caledonian Record
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO ...  Caledonian Record
Source →
general 2026-03-10
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study - Bitget
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study  Bitget
Source →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Biologics CDMOs → Cell Therapy CDMOs →